Are the Hydantoin-1,3,5-triazine 5-HT
1,3,5-triazine
5-HT6R antagonist
ADME-Tox parameters
hydantoin
obesity
procognitive effect
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 Dec 2019
06 Dec 2019
Historique:
received:
21
10
2019
revised:
21
11
2019
accepted:
03
12
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
6
5
2020
Statut:
epublish
Résumé
Though the 5-HT
Identifiants
pubmed: 31817628
pii: molecules24244472
doi: 10.3390/molecules24244472
pmc: PMC6943527
pii:
doi:
Substances chimiques
Anti-Obesity Agents
0
Hydantoins
0
Receptors, Serotonin
0
Serotonin Antagonists
0
Triazines
0
serotonin 6 receptor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Narodowe Centrum Nauki
ID : UMO-2015/17/B/NZ7/02973 and UMO-2016/21/N/NZ7/03265 and UMO-2018/31/B/NZ7/02160
Références
Pharm Res. 2008 Jul;25(7):1511-20
pubmed: 18185985
Pharmacol Ther. 2008 Feb;117(2):207-31
pubmed: 18068807
Eur J Med Chem. 2019 Oct 1;179:1-15
pubmed: 31229883
J Med Chem. 2005 Nov 3;48(22):6970-9
pubmed: 16250655
Int J Mol Sci. 2019 Jul 12;20(14):null
pubmed: 31336820
F1000 Biol Rep. 2009 Nov 26;1:87
pubmed: 20948603
ACS Chem Neurosci. 2016 Jul 20;7(7):972-83
pubmed: 27100049
Eur J Med Chem. 2018 Feb 10;145:790-804
pubmed: 29407591
J Med Chem. 2015 Oct 22;58(20):7901-12
pubmed: 26099069
Metab Brain Dis. 2018 Jun;33(3):733-740
pubmed: 29297106
Bioorg Med Chem Lett. 2018 Mar 1;28(5):878-883
pubmed: 29439902
J Med Chem. 2014 Sep 11;57(17):7160-81
pubmed: 24850589
J Endocrinol Invest. 2018 May;41(5):609-619
pubmed: 29110282
Curr Opin Pharmacol. 2011 Feb;11(1):52-8
pubmed: 21330209
ACS Med Chem Lett. 2017 Mar 27;8(4):390-394
pubmed: 28435524
Bioorg Chem. 2019 Mar;84:319-325
pubmed: 30530073
Eur J Med Chem. 2017 Jul 28;135:117-124
pubmed: 28441580
Front Neurosci. 2017 Feb 08;11:50
pubmed: 28228713
Behav Pharmacol. 2019 Feb;30(1):16-35
pubmed: 29847336
Br J Pharmacol. 2011 Oct;164(4):1248-62
pubmed: 21265828
Eur J Pharmacol. 2016 Apr 5;776:146-55
pubmed: 26896778
Molecules. 2018 Oct 03;23(10):null
pubmed: 30282913
ACS Med Chem Lett. 2016 Apr 07;7(6):618-22
pubmed: 27326337
ACS Chem Neurosci. 2015 Jul 15;6(7):970-86
pubmed: 25746856
Molecules. 2017 Dec 14;22(12):null
pubmed: 29240714
Pharmacol Biochem Behav. 1986 Mar;24(3):525-9
pubmed: 2871560
Chem Biol Drug Des. 2017 Dec;90(6):1295-1306
pubmed: 28886235
Rev Neurosci. 2014;25(3):367-82
pubmed: 24501158
Exp Neurobiol. 2011 Dec;20(4):159-68
pubmed: 22355260
Medchemcomm. 2018 Sep 25;9(11):1882-1890
pubmed: 30568756
Mol Pharmacol. 1993 Mar;43(3):320-7
pubmed: 7680751
Br J Pharmacol. 2018 Jul;175(14):2897-2910
pubmed: 29486058
Drug Metab Dispos. 1999 Nov;27(11):1350-9
pubmed: 10534321
Metab Brain Dis. 2015 Dec;30(6):1487-94
pubmed: 26419385
Pharm Res. 2001 Oct;18(10):1420-5
pubmed: 11697467
Neuro Endocrinol Lett. 2009;30 Suppl 1:101-5
pubmed: 20027153
Neuropharmacology. 2017 Oct;125:50-63
pubmed: 28711518
Biochem Biophys Res Commun. 1993 May 28;193(1):268-76
pubmed: 8389146
Behav Brain Res. 1988 Nov 1;31(1):47-59
pubmed: 3228475
J Med Chem. 2017 Mar 9;60(5):1843-1859
pubmed: 28212021
ACS Med Chem Lett. 2012 Jun 20;3(8):650-2
pubmed: 24900525
Rev Neurosci. 2014;25(3):451-67
pubmed: 24867282